Loading content

The table below presents a summary of perpetual preferred stock outstanding at April 16, 2024

The table below presents a summary of perpetual preferred stock outstanding at April 16, 2024
Name (1) CUSIP Ticker Issue Date Per Annum Dividend Rate Dividend Payment Dates Dividend Type Callable on or After (2)
Series B 060505203 n/a Jun 1997 7.000% Jan 25, Apr 25, Jul 25, Oct 25 Cumulative Non-callable
Series E *,(3) 060505815 BAC PrE Nov 2006 Greater of 3-month CME Term SOFR + 61.161 bps or 4% Feb 15, May 15, Aug 15, Nov 15 Non-cumulative 11/15/2011
Series F *,(4) 060505377 n/a Mar 2012 Greater of 3-month CME Term SOFR + 66.161 bps or 4% Mar 15, Jun 15, Sep 15. Dec 15 Non-cumulative 3/15/2012
Series G *,(4) 060505385 n/a Mar 2012 Greater of 3-month CME Term SOFR + 66.161 bps or 4% Mar 15, Jun 15, Sep 15, Dec 15 Non-cumulative 3/15/2012
Series L Convertible 060505682 BAC PrL Jan 2008 7.250% Jan 30, Apr 30, Jul 30, Oct 30 Non-cumulative Non-callable
Series U *,(5) 060505ED2 n/a May 2013 5.200% to, but excluding, Jun 1, 2023; 3-month CME Term SOFR + 339.661 bps thereafter

Fixed: Jun 1, Dec 1 Floating Beginning 9/1/2023: Mar 1, Jun 1, Sep 1, Dec 1

Non-cumulative 6/1/2023
Series X *,(5) 060505EH3 n/a Sep 2014 6.250% to, but excluding Sep 5, 2024; 3-month CME Term SOFR + 396.661 bps thereafter

Fixed: Mar 5, Sep 5 Floating Beginning 12/5/2024: Mar 5, Jun 5, Sep 5, Dec 5

Non-cumulative 9/5/2024
Series Z *,(5) 060505EL4 n/a Oct 2014 6.500% to, but excluding Oct 23, 2024; 3-month CME Term SOFR + 443.561 bps thereafter

Fixed: Apr 23, Oct 23 Floating Beginning 1/23/2025: Jan 23, Apr 23, Jul 23, Oct 23

Non-cumulative 10/23/2024
Series AA *,(5) 060505EN0 n/a Mar 2015 6.100% to, but excluding Mar 17, 2025; 3-month CME Term SOFR + 415.961 bps thereafter

Fixed: Mar 17, Sep 17 Floating Beginning 6/17/2025: Mar 17, Jun 17, Sep 17, Dec 17

Non-cumulative 3/17/2025
Series DD *,(5) 060505EU4 n/a Mar 2016 6.300% to, but excluding, Mar 10, 2026; 3-month CME Term SOFR + 481.461 bps thereafter

Fixed: Mar 10, Sep 10 Floating Beginning 6/10/2026: Mar 10, Jun 10, Sep 10, Dec 10

Non-cumulative 3/10/2026
Series FF *,(5) 060505FL3 n/a Mar 2018 5.875% to, but excluding, March 15, 2028; 3-month CME Term SOFR + 319.261 bps thereafter

Fixed: Mar 15, Sep 15 Floating Beginning 6/15/2028: Mar 15, Jun 15, Sep 15, Dec 15

Non-cumulative 3/15/2028
Series GG (3) 060505229 BAC PrB May 2018 6.000% Feb 16, May 16, Aug 16, Nov 16 Non-cumulative 5/16/2023
Series HH (3) 060505195 BAC PrK Jul 2018 5.875% Jan 24, Apr 24, Jul 24, Oct 24 Non-cumulative 7/24/2023
Series JJ *,(5) 060505FP4 n/a Jun 2019 5.125% to, but excluding, Jun 20, 2024; 3-month CME Term SOFR + 355.361 bps thereafter

Fixed: Jun 20, Dec 20 Floating Beginning 9/20/2024: Mar 20, Jun 20, Sep 20, Dec 20

Non-cumulative 6/20/2024
Series KK (3) 06053U601 BAC PrM Jun 2019 5.375%

Mar 25, Jun 25, Sep 25, Dec 25

Non-cumulative 6/25/2024
Series LL (3) 06055H202 BAC PrN Sep 2019 5.000% Mar 17, Jun 17, Sep 17, Dec 17 Non-cumulative 9/17/2024
Series MM *,(5) 060505FQ2 n/a Jan 2020 4.300% to, but excluding, Jan 28, 2025; 3-month CME Term SOFR + 292.561 bps thereafter

Fixed: Jan 28, Jul 28 Floating Beginning 4/28/2025: Jan 28, Apr 28, Jul 28, Oct 28

Non-cumulative 1/28/2025
Series NN (3) 06055H400 BAC PrO Oct 2020 4.375%

Feb 3, May 3, Aug 3, Nov 3

Non-cumulative 11/3/2025
Series PP (3) 06055H608 BAC PrP Jan 2021 4.125%

Feb 2, May 2, Aug 2, Nov 2

Non-cumulative 2/2/2026
Series QQ (3) 06055H806 BAC PrQ Oct 2021 4.250%

Feb 17, May 17, Aug 17, Nov 17

Non-cumulative 11/17/2026
Series RR (7) 060505GB4 n/a Jan 2022 4.375% to, but excluding, Jan 27, 2027; 5-year UST + 276 bps thereafter Jan 27, April 27, Jul 27, Oct 27 Non-cumulative 1/27/2027
Series SS (3) 06055H871 BAC PrS Jan 2022 4.750%

Feb 17, May 17, Aug 17, Nov 17

Non-cumulative 02/17/2027
Series TT (7) 06055HAB9 n/a Apr 2022 6.125% to, but excluding, Apr 27, 2027; 5-year UST + 323.1 bps thereafter Jan 27, Apr 27, Jul 27, Oct 27 Non-cumulative 4/27/2027
Series 1 *,(6) 060505633 BML PrG Nov 2004 Greater of 3-month CME Term SOFR + 101.161 bps or 3% Feb 28, May 28, Aug 28, Nov 28 Non-cumulative 11/28/2009
Series 2 *,(6) 060505625 BML PrH Mar 2005 Greater of 3-month CME Term SOFR + 91.161 bps or 3% Feb 28, May 28, Aug 28, Nov 28 Non-cumulative 11/28/2009
Series 4 *,(6) 060505591 BML PrJ Nov 2005 Greater of 3-month CME Term SOFR + 101.161 bps or 4% Feb 28, May 28, Aug 28, Nov 28 Non-cumulative 11/28/2010
Series 5 *,(6) 060505583 BML PrL Mar 2007 Greater of 3-month CME Term SOFR + 76.161 bps or 4% Feb 21, May 21, Aug 21, Nov 21 Non-cumulative 5/21/2012

*The floating rate component of the Per Annum Dividend Rate listed for this security reflects the replacement of its original USD LIBOR reference rate with CME Term SOFR plus the applicable tenor spread adjustment prescribed by rules issued by the Board of Governors of the Federal Reserve System as directed by the Adjustable Interest Rate (LIBOR) Act enacted by the U.S. Congress in March 2022. As further explained in our press release on March 31, 2023, for dividend determinations after June 30, 2023, the CME Term SOFR Reference Rate published for the three-month tenor (that corresponds to the three-month USD LIBOR tenor), as administered by CME Group Benchmark Administration, Ltd. (“CME Term SOFR”), plus the three-month tenor spread adjustment (26.161 bps) will be the reference rate for calculations or determinations of applicable dividend or distribution payments for our impacted USD LIBOR preferred stock. The Per Annum Dividend rate listed also includes any credit spread above USD LIBOR that was prescribed in the original terms for the security. Please note that the prospectus linked at left for this security pre-dates the replacement of USD LIBOR with CME Term SOFR and thus only includes its original terms that referenced USD LIBOR for the determination of floating rate dividend payments.

(1) Each series of preferred stock was issued by Bank of America Corporation (the "Corporation"). The final prospectus supplement for each series, if available, is hyperlinked in first column of the table above. For more information about the Corporation's series of preferred stock, including certain voting rights, see the Corporation's Amended and Restated Certificate of Incorporation filed with the SEC.

(2) The Corporation may redeem series of preferred stock on or after the redemption date, in whole or in part, at its option, at the applicable redemption price plus declared and unpaid dividends. Series B and Series L preferred stock do not have early redemption/call rights.

(3) Ownership is held in the form of depositary shares each representing a 1/1000th interest in a share of preferred stock paying a quarterly cash dividend, if and when declared.

(4) Series F and Series G are held by BAC Capital Trust XIII and BAC Capital Trust XIV, respectively. Interests in BAC Capital Trust XIII and BAC Capital Trust XIV are represented by Hybrid Income Term Securities (HITS).

(5) Ownership is held in the form of depositary shares each representing a 1/25th interest in a share of preferred stock, paying a semi-annual cash dividend, if and when declared, until the date the securities first become redeemable, then adjusts to a quarterly cash dividend, if and when declared, thereafter.

(6) Ownership is held in the form of depositary shares, each representing a 1/1200th interest in a share of preferred stock, paying a quarterly cash dividend, if and when declared.

(7) Ownership is held in the form of depositary shares, each representing 1/25th interest in a share of preferred stock, paying a quarterly cash dividend, if and when declared.

For more detail on any announced redemption of these securities, please see Press Releases and Quarterly Earnings.

Note: n/a = not applicable

Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use (QuoteMedia).